vs
Side-by-side financial comparison of Aterian, Inc. (ATER) and Protalix BioTherapeutics, Inc. (PLX). Click either name above to swap in a different company.
Aterian, Inc. is the larger business by last-quarter revenue ($15.1M vs $9.1M, roughly 1.7× Protalix BioTherapeutics, Inc.). Aterian, Inc. runs the higher net margin — -52.5% vs -60.3%, a 7.8% gap on every dollar of revenue. On growth, Aterian, Inc. posted the faster year-over-year revenue change (-38.5% vs -49.9%). Protalix BioTherapeutics, Inc. produced more free cash flow last quarter ($1.6M vs $-1.0M). Over the past eight quarters, Protalix BioTherapeutics, Inc.'s revenue compounded faster (-6.7% CAGR vs -13.5%).
Aterian, Inc. is a technology-enabled consumer products company that leverages artificial intelligence and data analytics to identify market demand, develop, source and distribute a wide portfolio of affordable goods spanning home improvement, wellness, personal care, pet supplies and outdoor recreation. It primarily sells its products through leading global e-commerce platforms, with core markets covering North America and Europe.
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
ATER vs PLX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.1M | $9.1M |
| Net Profit | $-7.9M | $-5.5M |
| Gross Margin | 56.1% | 49.4% |
| Operating Margin | -51.1% | -51.1% |
| Net Margin | -52.5% | -60.3% |
| Revenue YoY | -38.5% | -49.9% |
| Net Profit YoY | -512.2% | -184.8% |
| EPS (diluted) | — | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.1M | $9.1M | ||
| Q3 25 | $19.0M | $17.9M | ||
| Q2 25 | $19.5M | $15.7M | ||
| Q1 25 | $15.4M | $10.1M | ||
| Q4 24 | $24.6M | $18.2M | ||
| Q3 24 | $26.2M | $18.0M | ||
| Q2 24 | $28.0M | $13.5M | ||
| Q1 24 | $20.2M | — |
| Q4 25 | $-7.9M | $-5.5M | ||
| Q3 25 | $-2.3M | $2.4M | ||
| Q2 25 | $-4.9M | $164.0K | ||
| Q1 25 | $-3.9M | $-3.6M | ||
| Q4 24 | $-1.3M | $6.5M | ||
| Q3 24 | $-1.8M | $3.2M | ||
| Q2 24 | $-3.6M | $-2.2M | ||
| Q1 24 | $-5.2M | — |
| Q4 25 | 56.1% | 49.4% | ||
| Q3 25 | 56.1% | 53.4% | ||
| Q2 25 | 54.3% | 62.5% | ||
| Q1 25 | 61.4% | 19.1% | ||
| Q4 24 | 63.4% | 78.7% | ||
| Q3 24 | 60.3% | 53.4% | ||
| Q2 24 | 60.4% | 29.8% | ||
| Q1 24 | 65.1% | — |
| Q4 25 | -51.1% | -51.1% | ||
| Q3 25 | -10.7% | 11.9% | ||
| Q2 25 | -23.1% | 7.5% | ||
| Q1 25 | -24.1% | -41.0% | ||
| Q4 24 | -6.5% | 39.6% | ||
| Q3 24 | -6.6% | 22.2% | ||
| Q2 24 | -11.5% | -18.0% | ||
| Q1 24 | -26.1% | — |
| Q4 25 | -52.5% | -60.3% | ||
| Q3 25 | -12.0% | 13.2% | ||
| Q2 25 | -25.0% | 1.0% | ||
| Q1 25 | -25.4% | -35.8% | ||
| Q4 24 | -5.3% | 35.6% | ||
| Q3 24 | -6.8% | 18.0% | ||
| Q2 24 | -13.0% | -16.4% | ||
| Q1 24 | -25.5% | — |
| Q4 25 | — | $-0.06 | ||
| Q3 25 | — | $0.03 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.03 | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.9M | $14.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.2M | $48.2M |
| Total Assets | $29.6M | $82.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9M | $14.7M | ||
| Q3 25 | $7.6M | $13.6M | ||
| Q2 25 | $10.5M | $17.9M | ||
| Q1 25 | $14.3M | $19.5M | ||
| Q4 24 | $18.0M | $19.8M | ||
| Q3 24 | $16.1M | $27.4M | ||
| Q2 24 | $20.3M | $23.4M | ||
| Q1 24 | $17.5M | — |
| Q4 25 | $15.2M | $48.2M | ||
| Q3 25 | $22.6M | $52.9M | ||
| Q2 25 | $24.3M | $49.9M | ||
| Q1 25 | $27.0M | $45.2M | ||
| Q4 24 | $30.0M | $43.2M | ||
| Q3 24 | $30.6M | $32.4M | ||
| Q2 24 | $30.9M | $28.6M | ||
| Q1 24 | $33.0M | — |
| Q4 25 | $29.6M | $82.3M | ||
| Q3 25 | $40.1M | $82.3M | ||
| Q2 25 | $45.4M | $78.5M | ||
| Q1 25 | $49.8M | $73.9M | ||
| Q4 24 | $49.5M | $73.4M | ||
| Q3 24 | $52.1M | $61.6M | ||
| Q2 24 | $59.9M | $91.5M | ||
| Q1 24 | $55.7M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.0M | $2.0M |
| Free Cash FlowOCF − Capex | $-1.0M | $1.6M |
| FCF MarginFCF / Revenue | -6.9% | 17.8% |
| Capex IntensityCapex / Revenue | 0.0% | 4.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.0M | $2.0M | ||
| Q3 25 | $-1.6M | $-3.7M | ||
| Q2 25 | $-4.4M | $-5.2M | ||
| Q1 25 | $-3.9M | $-5.1M | ||
| Q4 24 | $-9.0K | $4.0M | ||
| Q3 24 | $-722.0K | $4.1M | ||
| Q2 24 | $2.9M | $-3.6M | ||
| Q1 24 | $-6.0K | — |
| Q4 25 | $-1.0M | $1.6M | ||
| Q3 25 | $-1.6M | $-4.2M | ||
| Q2 25 | $-4.4M | $-5.7M | ||
| Q1 25 | — | $-5.4M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $4.0M | ||
| Q2 24 | $2.9M | $-3.8M | ||
| Q1 24 | $-42.0K | — |
| Q4 25 | -6.9% | 17.8% | ||
| Q3 25 | -8.4% | -23.7% | ||
| Q2 25 | -22.7% | -36.2% | ||
| Q1 25 | — | -53.0% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | — | 22.4% | ||
| Q2 24 | 10.3% | -28.1% | ||
| Q1 24 | -0.2% | — |
| Q4 25 | 0.0% | 4.4% | ||
| Q3 25 | 0.2% | 2.8% | ||
| Q2 25 | 0.0% | 2.8% | ||
| Q1 25 | 0.0% | 3.0% | ||
| Q4 24 | 0.0% | 2.3% | ||
| Q3 24 | 0.0% | 0.5% | ||
| Q2 24 | 0.0% | 1.3% | ||
| Q1 24 | 0.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATER
| Sales Channel Directly To Consumer | $13.1M | 87% |
| Heating Cooling And Air Quality | $2.1M | 14% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
